Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients

Study summary

The established Insight(TM) mHealth Platform, a component of the Stephenson Cancer Center (SCC) mHealth Shared Resource will be used to create the "Symptom Tracker" app. The Symptom Tracker (Insight(TM)) app will enable real-time monitoring of cancer patient symptoms that are consistent with early signs of SARS-CoV-2 infection in this high-risk population by automatically (and securely) transferring this information to health care providers. The primary aim of this study is to determine the feasibility, ease of use, and perceived utility of this app to monitor symptoms and health risk behaviors among cancer patients currently receiving chemotherapy.

Ask AI to explain this study

Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedmHealth Assessments

The study team can explain what participation involves.

Who it may be forSars-CoV2 · Covid-19

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 24, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Oklahoma

Study sponsor

Study overview

What this study is about

Purpose: Screening
Study type: Interventional
Phase: Not applicable
Sponsor: University of Oklahoma
Interventions being studied: Other: mHealth Assessments

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Chemotherapy→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Demonstrate \> 6th grade English literacy level (i.e., phone based EMAs require \>6th grade literacy) 2. Present for care at the Stephenson Cancer Center at the University of Oklahoma Health Sciences Center 3. Are currently receiving systemic chemotherapy by intravenous infusion or by orally delivered medication 4. Are greater than or equal to 18 years of age 5. Are willing and able to complete surveys on their personal smartphone or a study provided smartphone 6. Are willing and able to provide informed consent

Reasons someone may not be able to joinExclusion criteria

None

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Stephenson Cancer CenterOklahoma City, Oklahoma

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 24, 2023. Always confirm current availability with the study team.

View original record ↗